![]() |
ChannelsRecent blog posts
Welcome to the PLoS BlogBlogrollWho Links to Us?Open access anxiety in the publish or perish worldSubmitted by Jocalyn Clark on Wed, 2008-09-03 11:31.
I gave research rounds at a university hospital yesterday on a topic that seems to simultaneously inspire and provoke: open access publishing. My sense—having socialized as a medical academic before defecting to the editorial world—is that one thing alone matters: Publish or Perish. (Or as my former colleague Joel Ray says, “PubMed-ish or perish.”). This will come as no surprise to anyone in the academic health sciences. Publishing is the chief currency in this universe, the main source of validation of one’s research, and often the key indicator of academic success. Promotion and tenure committees (and colleagues, chairs, deans) value peer-reviewed publications above all;...that is, regrettably, even above clinical performance or community service. That “publish or perish” (PorP) generates perverse incentives and sometimes bad publication behaviour is a topic for another day. But as the broader scientific landscape is shifting toward the importance of open access to the literature, the traditions of medical publishing—which prop up PorP—persist: the “top five” hierarchy, the importance of the impact factor, the codified order of authorship etcetera. To succeed in medical academia means to play by these rules, but these rules work to eclipse an interest in disseminating one’s work widely, the central benefit of open access (OA). They do so partly because traditional medical publishers (except for the BMJ) do not as of yet provide OA. But these rules also create anxiety among medical academics because of some common misconceptions about open access publishing: OA publications don’t use peer review, OA journals are of lesser quality and reputation, authors “buy” their OA publications, and anyone can publish in an OA journal. Debunking these misconceptions surely is one of the key challenges to the open access movement in medicine. So after a lively discussion with colleagues during research rounds I was grateful this morning to receive this week’s edition of Peter Suber’s outstanding newsletter. In it he takes on this idea that OA cannot equate with prestige. Peter’s treatise is long but well worth reading. I was particularly interested in the following arguments that have relevance to publishing in medicine: On incentives: On prestige: (OA journals like PLoS Medicine, whose impact factors have consistently put it among the top 5 of general medical journals and whose influence means its articles are regularly cited in media and policy discussions). On promotion and tenure reviews: What I take from this is that we need in medical academia to care more about quality than prestige: the quality of our research, of our publication and dissemination goals, of the impact of our work, and of our hiring and promotion decisions. So instead of “Publish or Perish,” perhaps our mantra ought to be “Quality or Quit.” Trackback URL for this post:http://www.plos.org/cms/trackback/397
( categories: PLoS Medicine )
All Authors around the world must agree with your statements, I've just read in Open access anxiety in the publish or perish world, dear Jocalyn Clark. Unfortunately, between words and facts is the sea, as sounds an old italian proverb. The reasons are well-known, but I add another most prominent: Sponsors! For instance, diabetes mellitus can involve exclusively individuals with biophysical-semeiotic diabetic "and" dislipidemic constitutions, beside diabetic Inherited Real Risk (e.g., Stagnaro Sergio. Newborn-pathological Endoarteriolar Blocking Devices in Diabetic and Dislipidaemic Constitution and Diabetes Primary Prevention. The Lancet. March 06 2007. http://www.thelancet.com/journals/lancet/article/PIIS0140673607603316/ |
|
Any opinions expressed in these blogs are the personal views of the contributors, and do not necessarily represent the views or policies of PLoS. Use of the PLoS blogs and the PLoS Web Sites is at all times subject to our Terms of Use.
|
Recent comments